Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects.
Schaefer, Martin
Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects. [electronic resource] - Current drug abuse reviews Jun 2008 - 177-87 p. digital
Publication Type: Journal Article; Review
1874-4745
10.2174/1874473710801020177 doi
Alcoholism--epidemiology
Antidepressive Agents--therapeutic use
Antiviral Agents--adverse effects
Anxiety Disorders--chemically induced
Depressive Disorder--chemically induced
Drug Therapy, Combination
Hepatitis C, Chronic--drug therapy
Humans
Illicit Drugs
Interferon alpha-2
Interferon-alpha--adverse effects
Methadone--therapeutic use
Narcotics--therapeutic use
Patient Dropouts--psychology
Polyethylene Glycols--adverse effects
Recombinant Proteins
Ribavirin--adverse effects
Risk Factors
Substance Abuse, Intravenous--epidemiology
Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects. [electronic resource] - Current drug abuse reviews Jun 2008 - 177-87 p. digital
Publication Type: Journal Article; Review
1874-4745
10.2174/1874473710801020177 doi
Alcoholism--epidemiology
Antidepressive Agents--therapeutic use
Antiviral Agents--adverse effects
Anxiety Disorders--chemically induced
Depressive Disorder--chemically induced
Drug Therapy, Combination
Hepatitis C, Chronic--drug therapy
Humans
Illicit Drugs
Interferon alpha-2
Interferon-alpha--adverse effects
Methadone--therapeutic use
Narcotics--therapeutic use
Patient Dropouts--psychology
Polyethylene Glycols--adverse effects
Recombinant Proteins
Ribavirin--adverse effects
Risk Factors
Substance Abuse, Intravenous--epidemiology